Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-25-064
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.242 Mental Health Research Grants
- 93.866 Aging Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- For Profit Organizations
- Tribal Organizations (Not Federally Recognized)
- Special District Governments
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Small Businesses
- Non-501(c)(3) Nonprofits
- County Governments
- Independent School Districts
- Other
- State Governments
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of Health and Human Services, through the National Institutes of Health, is offering the "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)" grant opportunity. The goal is to fund studies that will enhance the understanding of mechanisms associated with neuropsychiatric symptoms in individuals with Alzheimer's disease or Alzheimer's-related dementias. The findings are expected to advance the mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS, and may provide insight into novel therapeutic targets. Eligible applicant types include for-profit organizations, nonprofits, higher education institutions, and state/local governments. The application deadline is September 7, 2026.
This grant opportunity is funded under the Mental Health Research Grants (CFDA 93.242) and Aging Research (CFDA 93.866) programs. Recent awards in these programs have ranged from $35,000 to over $3 million, with typical project durations of 2-5 years. The research activities are expected to be conducted at the facilities of the recipient organizations across the United States.
Synopsis
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advanceadavnce mechanistic understanding of both biobehavioral and neurobiologfical pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-064-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity